Carregant...
23.2 ALPHA 7 NICOTINIC MODULATORS REVERSE THE HYPERDOPAMINERGIC TONE IN THE MAM MODEL OF SCHIZOPHRENIA
BACKGROUND: While dopaminergic antagonists have been the mainstay of schizophrenia pharmacotherapy, they suffer from low compliance and are fraught with side effects. A more effective approach would be to intervene at the site of dysfunction within the schizophrenia brain, which increasing evidence...
Guardat en:
| Publicat a: | Schizophr Bull |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Oxford University Press
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6455873/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/schbul/sbz022.092 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|